Standard Biotools (LAB) Net Cash Flow (2016 - 2025)
Historic Net Cash Flow for Standard Biotools (LAB) over the last 17 years, with Q3 2025 value amounting to -$29.0 million.
- Standard Biotools' Net Cash Flow rose 5065.02% to -$29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.6 million, marking a year-over-year decrease of 16116.97%. This contributed to the annual value of $117.1 million for FY2024, which is 49219.0% up from last year.
- According to the latest figures from Q3 2025, Standard Biotools' Net Cash Flow is -$29.0 million, which was up 5065.02% from $6.9 million recorded in Q2 2025.
- In the past 5 years, Standard Biotools' Net Cash Flow ranged from a high of $235.9 million in Q1 2024 and a low of -$62.5 million during Q3 2023
- In the last 5 years, Standard Biotools' Net Cash Flow had a median value of -$13.9 million in 2022 and averaged $3.3 million.
- Examining YoY changes over the last 5 years, Standard Biotools' Net Cash Flow showed a top increase of 254635.29% in 2022 and a maximum decrease of 90652.65% in 2022.
- Standard Biotools' Net Cash Flow (Quarter) stood at -$850000.0 in 2021, then surged by 2546.35% to $20.8 million in 2022, then plummeted by 235.52% to -$28.2 million in 2023, then crashed by 52.06% to -$42.9 million in 2024, then skyrocketed by 32.34% to -$29.0 million in 2025.
- Its Net Cash Flow was -$29.0 million in Q3 2025, compared to $6.9 million in Q2 2025 and -$15.7 million in Q1 2025.